Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Cash flows from operating activities
Net income	$ 16,790	$ 14,346
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
Depreciation and amortization expense	6,131	5,696
Provision for doubtful accounts	136	104
Deferred income tax benefit	(765)	(1,179)
Share-based compensation expense	4,538	3,574
Gain on disposal of fixed assets	0	(5)
Amortization of discount on accounts receivable	(58)	(34)
Amortization of right-of-use assets	480	448
Change in fair value of contingent earn-out consideration	(0)	1,374
Accounts receivable	(14,889)	124,269
Inventory	(1,477)	(579)
Prepaid expenses and other current assets	(1,903)	(3,118)
Accounts payable and accrued expenses	33,183	(116,139)
Lease liability, net	(597)	(502)
Other assets and liabilities	2,525	240
Net cash and cash equivalents provided by operating activities	44,094	28,495
Cash flows from investing activities
Purchases of property and equipment	(1,778)	(1,672)
Payment for acquisition, net of cash acquired	(8,228)	0
Net cash and cash equivalents used in investing activities	(10,006)	(1,672)
Cash flows from financing activities
Purchase of treasury stock	(1,821)	(1,730)
Borrowings under credit facilities	9,000	0
Repayments of borrowings under credit facilities	(10,076)	0
Repayments of borrowings under term loan	(145)	(418)
Dividends paid	0	(2,305)
Contingent consideration paid	0	(3,559)
Net cash and cash equivalents used in financing activities	(3,042)	(8,012)
Effect of foreign exchange rate on cash and cash equivalents	(660)	1,253
Net increase in cash and cash equivalents	30,386	20,064
Cash and cash equivalents at beginning of period	36,563	29,778
Cash and cash equivalents at end of period	66,949	49,842
Supplementary disclosure of cash flow information:
Income taxes paid	8,062	6,889
Interest paid	$ 122	$ 114